Sterility Testing: The Final Checkpoint for Sterile Product Assurance
The safety of a product marketed as sterile is based on the scientific validation of the production process and the sterilization cycle. The final link in this chain of validation is the direct testing to determine whether the product contains any viable microorganisms. Sterility testing is the fundamental analysis that verifies the microbiological safety of medical devices and pharmaceutical products declared to be sterile.
Our laboratory conducts sterility tests in accordance with ISO 11737-2:2019, Ph. Eur. 2.6.1, and USP <71>, under GLP principles.
Why Is a Sterility Test Performed?
The primary purpose of a sterility test is to demonstrate that the product is microbiologically safe and that the claim of sterility has a scientific basis. Sterility is not achieved by a single test result alone; rather, it is a process outcome ensured through the combined implementation of bioburden control, validation of the sterilization process, and routine production control. Within this framework, the sterility test serves as an independent control point that verifies the microbiological status of the process and the product.
The second fundamental function of the test is regulatory compliance. Medical device and pharmaceutical product regulations require the submission of sterility data for the market release of sterile products. Sterility test results are directly referenced in technical dossiers under the EU MDR, in pharmacopoeia compliance documents, and in sterilization validation dossiers (ISO 11135, ISO 11137, ISO 17665). Third, the test contributes to the early detection of deviations in the production process; recurring or unexpected results require the initiation of a systematic evaluation in areas such as environmental control, personnel hygiene, or packaging integrity.
For this reason, the sterility test should not be viewed merely as a “presence/absence of growth” check. The results must be validated within the product matrix using the applied method and presented alongside a defensible data package for regulatory submission.
Which Products Require Sterility Testing?
Sterility testing covers all products marketed as sterile that come into direct contact with body cavities, the bloodstream, or tissue. The product’s physical form, packaging, and intended use determine the scope of the test and the sampling approach. The table below summarizes the main product groups for which sterility testing is performed.
| Product Group | Examples | Primary Purpose of the Test |
|---|---|---|
| Implantable medical devices | Orthopedic implants, screws, plates, dental implants, stents | Sterilization validation and release control |
| Single-use devices | Catheters, syringes, surgical sets, drainage systems | Product safety and batch release |
| Parenteral drugs and biologics | Injectable solutions, infusion fluids, vaccines, cell therapies | Pharmacopoeia compliance and patient safety |
| Wound care and dressing products | Sterile wound dressings, gauze, surgical drapes | Microbiological safety and validation of label claims |
| Packaging and packaging systems | Sterile barrier packaging, primary packaging | Evaluation of the impact of packaging integrity on sterility |
| Sterile components and raw materials | Components and auxiliary materials supplied in a sterile state | Incoming inspection and compliance with the production process |
Key Factors Determining Test Validity
The regulatory value of a sterility test depends not only on the results table but also on the conditions under which the results were obtained. Therefore, the testing process begins with an evaluation of the product’s physicochemical properties and, if applicable, its antimicrobial activity. If the product’s own components can inhibit microbial growth, it must be experimentally demonstrated that the method used can detect microorganisms within this matrix. Results obtained without this validation are not considered valid.
The second factor is the test’s relevance to the product and process context. Sterility tests for validation purposes in medical devices and routine release tests for pharmaceutical products are subject to different standards; while ISO 11737-2:2019 regulates tests within the scope of process validation, Ph. Eur. 2.6.1 and USP <71> define the framework for routine release tests. The correct selection of which standard to use for which purpose directly affects the acceptability of the application.
The third element is full compliance with standards regarding sampling and incubation processes. The 14-day incubation period defined in pharmacopoeia texts is scientifically justified to ensure the detection of slow-growing or stressed microorganisms. Shortening this period or deviating from standard incubation conditions invalidates the test.
Scope of Services Offered by Our Laboratory
Our GLP-certified laboratory conducts sterility tests in accordance with ISO 11737-2:2019, Ph. Eur. 2.6.1, and USP <71>. Our scope of services includes determining a testing strategy based on the product and process context, method suitability validations, the performance of sterility tests, and the reporting of results.
Let’s work together to assess your product’s sterility testing needs, including which standards to follow and the scope of testing required. Our laboratory’s team of experts will determine the testing strategy best suited to your product group and target market, helping to expedite your regulatory process. Contact us to learn more and plan your project.










